Amneal Pharmaceuticals Inc. (AMRX) reached a 52-week high of $19.32 per share on Thursday, reflecting robust second-quarter performance and positive analyst revisions. The company’s market capitalization stands at $6.62 billion, with total returns over the past year climbing 88.05% and adjusted earnings per share (EPS) exceeding forecasts by 30%. Revenue for Q2 surpassed expectations by 5.1%, reaching $796.2 million against an anticipated $758.24 million, while adjusted EPS came in at $0.30, surpassing the $0.23 estimate.
Amneal Pharmaceuticals Stock Reaches 52-Week High on Q2 Surpasses
Amneal Pharmaceuticals Inc. hit a 52-week high of $19.32 amid strong second-quarter results and biosimilar growth.
PA
Priya Anand · Equities & Earnings Desk · 21 Sept 2026 · 16:40 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
